Here are the two major advantages of adjuvant vaccinations.
* You need less antigen.
- For every U.S. adjuvant-free vaccination, Canada/Europe can vaccinate
four adults or eight children (half dose) with adjuvant containing shots.
Theoretically, this means you can protect your population four times faster.
I assume you can expect less deaths if you can protect your population
four times faster.
Note: the production problems with GSK in Canada was not that the
company couldn't produce enough antigen in time (they exported a lot of bulk product),
but that they were not able to keep up with bottling of the vaccines
(To put it in bottles).
* Adjuvant vaccinations give better protection agains genetic shifts (mutations).
Meaning, if the virus mutates a bit, it's more likely that you don't have to
re-vaccinate your population. Considering that H1N1 will slowly turn into a
regular seasonal flu, and can stay active for the next 20 years, the current
adjuvant vaccinations can give long term (partial) protection.
The adjuvant stays in your body for some hours and not for days.
It has been used in Europe for many years. If there was any problem with
it, the Europeans would have stopped using it long time ago.
Adjuvant is also being used in many other vaccinations.
Considering that you can protect more people in a shorter time, it doesn't
make sense to me why a country would not want to use adjuvant
vaccinations ... with possibly the exception for expecting mothers.
Canada started a bit later than the U.S. with the vaccination program.
I don't have numbers, but I expect a larger percentage has received a
shot because relatively more shots are available.
* You need less antigen.
- For every U.S. adjuvant-free vaccination, Canada/Europe can vaccinate
four adults or eight children (half dose) with adjuvant containing shots.
Theoretically, this means you can protect your population four times faster.
I assume you can expect less deaths if you can protect your population
four times faster.
Note: the production problems with GSK in Canada was not that the
company couldn't produce enough antigen in time (they exported a lot of bulk product),
but that they were not able to keep up with bottling of the vaccines
(To put it in bottles).
* Adjuvant vaccinations give better protection agains genetic shifts (mutations).
Meaning, if the virus mutates a bit, it's more likely that you don't have to
re-vaccinate your population. Considering that H1N1 will slowly turn into a
regular seasonal flu, and can stay active for the next 20 years, the current
adjuvant vaccinations can give long term (partial) protection.
The adjuvant stays in your body for some hours and not for days.
It has been used in Europe for many years. If there was any problem with
it, the Europeans would have stopped using it long time ago.
Adjuvant is also being used in many other vaccinations.
Considering that you can protect more people in a shorter time, it doesn't
make sense to me why a country would not want to use adjuvant
vaccinations ... with possibly the exception for expecting mothers.
Canada started a bit later than the U.S. with the vaccination program.
I don't have numbers, but I expect a larger percentage has received a
shot because relatively more shots are available.
Comment